228 related articles for article (PubMed ID: 12390995)
21. Extended-interval Dosing of Gentamicin in Premature Neonates Born at <32 Weeks' Gestation and >7 Days of age.
Sundaram A; Alshaikh B; Dersch-Mills D; Dobry J; Akierman AR; Yusuf K
Clin Ther; 2017 Jun; 39(6):1233-1241. PubMed ID: 28579209
[TBL] [Abstract][Full Text] [Related]
22. Once daily gentamicin dosing in full term neonates.
Alsaedi SA
Saudi Med J; 2003 Sep; 24(9):978-81. PubMed ID: 12973482
[TBL] [Abstract][Full Text] [Related]
23. Population pharmacokinetics of vancomycin in premature Malaysian neonates: identification of predictors for dosing determination.
Lo YL; van Hasselt JG; Heng SC; Lim CT; Lee TC; Charles BG
Antimicrob Agents Chemother; 2010 Jun; 54(6):2626-32. PubMed ID: 20385872
[TBL] [Abstract][Full Text] [Related]
24. Establishment of a population pharmacokinetics model of vancomycin in 94 infants with septicemia and its application in individualized therapy.
Li Z; Li H; Wang C; Jiao Z; Xu F; Sun H
BMC Pharmacol Toxicol; 2021 May; 22(1):26. PubMed ID: 33947475
[TBL] [Abstract][Full Text] [Related]
25. Evaluation of vancomycin target trough attainment with published dosing regimens in the neonatal intensive care unit population.
Chung E; Lee SE; Abraham T; Saad NN; Gad A
J Neonatal Perinatal Med; 2019; 12(1):21-27. PubMed ID: 30149480
[TBL] [Abstract][Full Text] [Related]
26. The relationship between vancomycin AUC/MIC and trough concentration, age, dose, renal function in Chinese critically ill pediatric patients.
Chen J; Huang X; Bu S; Chen X; Zhou J; Liu X; Guo X; Li L; Zhang J
Pharmacol Res Perspect; 2021 Dec; 9(6):e00885. PubMed ID: 34664790
[TBL] [Abstract][Full Text] [Related]
27. Evaluation of the variability and safety of serum trough concentrations of vancomycin in patients admitted to the intensive care unit.
Qian X; Du G; Weng C; Zhou H; Zhou X
Int J Infect Dis; 2017 Jul; 60():17-22. PubMed ID: 28457752
[TBL] [Abstract][Full Text] [Related]
28. Pharmacokinetic comparison of nomogram-based and individualized vancomycin regimens in neonates.
Crumby T; Rinehart E; Carby MC; Kuhl D; Talati AJ
Am J Health Syst Pharm; 2009 Jan; 66(2):149-53. PubMed ID: 19139479
[TBL] [Abstract][Full Text] [Related]
29. Population Pharmacokinetics and Pharmacodynamic Target Attainment of Vancomycin in Neonates on Extracorporeal Life Support.
Cies JJ; Moore WS; Nichols K; Knoderer CA; Carella DM; Chopra A
Pediatr Crit Care Med; 2017 Oct; 18(10):977-985. PubMed ID: 28650363
[TBL] [Abstract][Full Text] [Related]
30. Inadequate vancomycin therapy in term and preterm neonates: a retrospective analysis of trough serum concentrations in relation to minimal inhibitory concentrations.
Sinkeler FS; de Haan TR; Hodiamont CJ; Bijleveld YA; Pajkrt D; Mathôt RA
BMC Pediatr; 2014 Jul; 14():193. PubMed ID: 25066951
[TBL] [Abstract][Full Text] [Related]
31. Relationship between vancomycin dosage and serum trough vancomycin concentrations in pediatric patients with cystic fibrosis.
Durham SH; Garza KB; Eiland LS
Am J Health Syst Pharm; 2016 Jul; 73(13):969-74. PubMed ID: 27325878
[TBL] [Abstract][Full Text] [Related]
32. Coagulase negative staphylococcal sepsis in neonates: do we need to adapt vancomycin dose or target?
Padari H; Oselin K; Tasa T; Metsvaht T; Lõivukene K; Lutsar I
BMC Pediatr; 2016 Dec; 16(1):206. PubMed ID: 27931193
[TBL] [Abstract][Full Text] [Related]
33. Evolution of empiric vancomycin dosing in a neonatal population.
Radu L; Bengry T; Akierman A; Alshaikh B; Yusuf K; Dersch-Mills D
J Perinatol; 2018 Dec; 38(12):1702-1707. PubMed ID: 30341404
[TBL] [Abstract][Full Text] [Related]
34. Vancomycin: pharmacokinetics and administration regimens in neonates.
de Hoog M; Mouton JW; van den Anker JN
Clin Pharmacokinet; 2004; 43(7):417-40. PubMed ID: 15139793
[TBL] [Abstract][Full Text] [Related]
35. Pharmacokinetics and dose requirements of vancomycin in neonates.
Grimsley C; Thomson AH
Arch Dis Child Fetal Neonatal Ed; 1999 Nov; 81(3):F221-7. PubMed ID: 10525029
[TBL] [Abstract][Full Text] [Related]
36. Once daily dose gentamicin in neonates - is our dosing correct?
Serane TV; Zengeya S; Penford G; Cooke J; Khanna G; McGregor-Colman E
Acta Paediatr; 2009 Jul; 98(7):1100-5. PubMed ID: 19397541
[TBL] [Abstract][Full Text] [Related]
37. Vancomycin serum concentrations in pediatric oncologic/hematologic intensive care patients.
Silva DC; Seixas GT; Araujo OR; Arduini RG; Carlesse FA; Petrilli AS
Braz J Infect Dis; 2012; 16(4):361-5. PubMed ID: 22846125
[TBL] [Abstract][Full Text] [Related]
38. The association of elevated trough serum vancomycin concentrations with obesity.
Richardson J; Scheetz M; O'Donnell EP
J Infect Chemother; 2015 Jul; 21(7):507-11. PubMed ID: 25851852
[TBL] [Abstract][Full Text] [Related]
39. Tobramycin population pharmacokinetics in neonates.
de Hoog M; Schoemaker RC; Mouton JW; van den Anker JN
Clin Pharmacol Ther; 1997 Oct; 62(4):392-9. PubMed ID: 9357390
[TBL] [Abstract][Full Text] [Related]
40. A randomized controlled trial of a vancomycin loading dose in children.
Demirjian A; Finkelstein Y; Nava-Ocampo A; Arnold A; Jones S; Monuteaux M; Sandora TJ; Patterson A; Harper MB
Pediatr Infect Dis J; 2013 Nov; 32(11):1217-23. PubMed ID: 23817340
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
